Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.Design Meta-analysis of randomised controlled trials.Data sources PubMed, Embase, Cumulative I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) 2015-04, Vol.350 (apr16 25), p.h1618-h1618
Hauptverfasser:	Navarese, Eliano Pio, Andreotti, Felicita, Schulze, Volker, Kołodziejczak, Michalina, Buffon, Antonino, Brouwer, Marc, Costa, Francesco, Kowalewski, Mariusz, Parati, Gianfranco, Lip, Gregory Y H, Kelm, Malte, Valgimigli, Marco
Format:	Artikel
Sprache:	eng
Schlagworte:	Angina pectoris Aspirin - therapeutic use Combined Modality Therapy Coronary Artery Disease - therapy Drug Administration Schedule Drug Therapy, Combination Drug-Eluting Stents Heart attacks Hemorrhage - chemically induced Hemorrhage - prevention & control Humans Models, Statistical Mortality Myocardial Infarction - etiology Myocardial Infarction - mortality Myocardial Infarction - prevention & control Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - therapeutic use Purinergic P2Y Receptor Antagonists - therapeutic use Randomized Controlled Trials as Topic Stents Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!